About
Mana.bio develops AI-powered lipid nanoparticle drug delivery systems for gene therapies, including DNA and RNA-based therapeutics and vaccines.
Explore Mana.bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.